あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/04/08 | 1,347 | 1,347 | 1,292 | 1,313 | -47 | -3.5% | 170,400 |
| 2022/04/07 | 1,328 | 1,362 | 1,315 | 1,360 | +26 | +1.9% | 129,500 |
| 2022/04/06 | 1,303 | 1,336 | 1,303 | 1,334 | +16 | +1.2% | 96,100 |
| 2022/04/05 | 1,333 | 1,345 | 1,312 | 1,318 | ±0 | ±0% | 112,600 |
| 2022/04/04 | 1,295 | 1,325 | 1,294 | 1,318 | +48 | +3.8% | 165,500 |
| 2022/04/01 | 1,250 | 1,279 | 1,234 | 1,270 | +7 | +0.6% | 117,200 |
| 2022/03/31 | 1,250 | 1,290 | 1,247 | 1,263 | +3 | +0.2% | 134,300 |
| 2022/03/30 | 1,267 | 1,300 | 1,252 | 1,260 | -3 | -0.2% | 181,500 |
| 2022/03/29 | 1,243 | 1,265 | 1,218 | 1,263 | +127 | +11.2% | 407,700 |
| 2022/03/28 | 1,157 | 1,157 | 1,131 | 1,136 | -21 | -1.8% | 30,900 |
| 2022/03/25 | 1,170 | 1,175 | 1,154 | 1,157 | -13 | -1.1% | 40,800 |
| 2022/03/24 | 1,153 | 1,171 | 1,137 | 1,170 | +5 | +0.4% | 64,000 |
| 2022/03/23 | 1,136 | 1,169 | 1,132 | 1,165 | +44 | +3.9% | 127,400 |
| 2022/03/22 | 1,164 | 1,164 | 1,112 | 1,121 | -27 | -2.4% | 111,700 |
| 2022/03/18 | 1,151 | 1,163 | 1,141 | 1,148 | -1 | -0.1% | 150,000 |
| 2022/03/17 | 1,145 | 1,154 | 1,137 | 1,149 | +22 | +2% | 114,000 |
| 2022/03/16 | 1,144 | 1,144 | 1,121 | 1,127 | +3 | +0.3% | 139,000 |
| 2022/03/15 | 1,110 | 1,135 | 1,100 | 1,124 | +7 | +0.6% | 79,700 |
| 2022/03/14 | 1,110 | 1,128 | 1,094 | 1,117 | +15 | +1.4% | 88,900 |
| 2022/03/11 | 1,108 | 1,112 | 1,086 | 1,102 | -18 | -1.6% | 82,500 |
| 2022/03/10 | 1,093 | 1,120 | 1,084 | 1,120 | +58 | +5.5% | 115,200 |
| 2022/03/09 | 1,048 | 1,084 | 1,045 | 1,062 | +9 | +0.9% | 120,200 |
| 2022/03/08 | 1,040 | 1,060 | 1,040 | 1,053 | -5 | -0.5% | 79,600 |
| 2022/03/07 | 1,077 | 1,084 | 1,043 | 1,058 | -38 | -3.5% | 101,400 |
| 2022/03/04 | 1,107 | 1,116 | 1,085 | 1,096 | -27 | -2.4% | 92,100 |
| 2022/03/03 | 1,139 | 1,142 | 1,118 | 1,123 | +4 | +0.4% | 57,400 |
| 2022/03/02 | 1,110 | 1,135 | 1,110 | 1,119 | -19 | -1.7% | 65,500 |
| 2022/03/01 | 1,150 | 1,160 | 1,131 | 1,138 | -8 | -0.7% | 61,300 |
| 2022/02/28 | 1,116 | 1,153 | 1,114 | 1,146 | +34 | +3.1% | 101,000 |
| 2022/02/25 | 1,100 | 1,122 | 1,089 | 1,112 | +30 | +2.8% | 72,800 |
| 2022/02/24 | 1,098 | 1,120 | 1,072 | 1,082 | -4 | -0.4% | 121,100 |
| 2022/02/22 | 1,060 | 1,093 | 1,056 | 1,086 | +18 | +1.7% | 80,600 |
| 2022/02/21 | 1,077 | 1,081 | 1,056 | 1,068 | -10 | -0.9% | 36,200 |
| 2022/02/18 | 1,055 | 1,078 | 1,044 | 1,078 | +8 | +0.7% | 45,200 |
| 2022/02/17 | 1,067 | 1,085 | 1,062 | 1,070 | +5 | +0.5% | 65,400 |
| 2022/02/16 | 1,050 | 1,066 | 1,049 | 1,065 | +23 | +2.2% | 100,400 |
| 2022/02/15 | 1,047 | 1,064 | 1,033 | 1,042 | -1 | -0.1% | 96,600 |
| 2022/02/14 | 1,024 | 1,050 | 1,007 | 1,043 | -3 | -0.3% | 97,700 |
| 2022/02/10 | 1,068 | 1,068 | 1,030 | 1,046 | -12 | -1.1% | 123,600 |
| 2022/02/09 | 1,046 | 1,059 | 1,025 | 1,058 | +12 | +1.1% | 143,900 |
| 2022/02/08 | 1,041 | 1,061 | 1,019 | 1,046 | +9 | +0.9% | 162,200 |
| 2022/02/07 | 1,036 | 1,046 | 1,024 | 1,037 | +1 | +0.1% | 71,600 |
| 2022/02/04 | 1,020 | 1,038 | 1,015 | 1,036 | +13 | +1.3% | 78,300 |
| 2022/02/03 | 1,030 | 1,035 | 1,015 | 1,023 | -14 | -1.4% | 115,000 |
| 2022/02/02 | 984 | 1,067 | 984 | 1,037 | +63 | +6.5% | 490,300 |
| 2022/02/01 | 981 | 989 | 970 | 974 | -7 | -0.7% | 46,000 |
| 2022/01/31 | 986 | 992 | 973 | 981 | -9 | -0.9% | 49,900 |
| 2022/01/28 | 975 | 1,003 | 970 | 990 | +30 | +3.1% | 93,400 |
| 2022/01/27 | 990 | 993 | 958 | 960 | -24 | -2.4% | 75,300 |
| 2022/01/26 | 975 | 986 | 970 | 984 | +7 | +0.7% | 29,800 |
751～
800
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 229,600円 | +0.3% | +2.7% | 2.18% | 13.02倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 栄研化 | 222,200円 | +0.4% | -8.4% | 2.39% | 28.52倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 49,400円 | -23.0% | - | 4.05% | - | 1.06倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ハートシード | 252,300円 | +174.2% | - | 0.00% | - | 8.59倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
市場注目の銘柄
チャート関連のコラム
